Literature DB >> 9931132

Effects of angiotensin II on sodium potassium pumps, endogenous ouabain, and aldosterone in bovine zona glomerulosa cells.

J R Shah1, J Laredo, B P Hamilton, J M Hamlyn.   

Abstract

Angiotensin (Ang) II stimulates secretions of aldosterone and an endogenous ouabain-like steroid (EO) from bovine adrenal zona glomerulosa (BAG) cells. The BAG cell sodium pump, a possible target of EO, affects aldosterone secretion although little is known about this pump. Here, we describe the effects of Ang II on the characteristics of this transporter and steroid secretions. Under serum-free conditions, 3H-ouabain bound to a single class of sites on BAG cells. Binding of label was time and concentration dependent, was sensitive to extracellular potassium ions, and was displaced by ouabain and digoxin with EC50 of approximately 218 and approximately 232 nmol/L, respectively. Sodium pump-mediated 86Rb uptake was inhibited by ouabain (EC50 approximately 301 nmol/L). Ang II dose dependently augmented secretions of EO and aldosterone, increased ouabain-sensitive 86Rb uptake and 3H-ouabain binding, and increased the affinity for 3H-ouabain binding (Kd, from 205 to 80 nmol/L) with no change in the maximal number of sodium pumps (5.45x10(6)) per cell. Losartan blocked all effects of Ang II except EO secretion, which was inhibited by PD123319. We conclude that BAG cells express sodium pumps in high density and bind ouabain to a single class of low-affinity sites. The characteristics of the sodium pumps protect BAG cells from EO autotoxicity but may exclude them from mediating feedback inhibition of EO secretion. The effects of Ang II on sodium pump activity, ouabain binding affinity, and aldosterone secretion are mediated via Ang II type 1 receptors, whereas Ang II type 2 receptors augment EO secretion. The role of the Ang II-mediated increase in the ouabain sensitivity of BAG cell sodium pumps in the secretions of aldosterone and EO remains to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9931132     DOI: 10.1161/01.hyp.33.1.373

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  7 in total

Review 1.  Endogenous digitalis: pathophysiologic roles and therapeutic applications.

Authors:  Alexei Y Bagrov; Joseph I Shapiro
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-10

Review 2.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

Review 3.  How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension.

Authors:  Mordecai P Blaustein; Frans H H Leenen; Ling Chen; Vera A Golovina; John M Hamlyn; Thomas L Pallone; James W Van Huysse; Jin Zhang; W Gil Wier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

4.  Endogenous ouabain and the renin-angiotensin-aldosterone system: distinct effects on Na handling and blood pressure in human hypertension.

Authors:  Paolo Manunta; John M Hamlyn; Marco Simonini; Elisabetta Messaggio; Chiara Lanzani; Maria Bracale; Giuseppe Argiolas; Nunzia Casamassima; Elena Brioni; Nicola Glorioso; Giuseppe Bianchi
Journal:  J Hypertens       Date:  2011-02       Impact factor: 4.844

Review 5.  Na+/Ca2+ exchange and Na+/K+-ATPase in the heart.

Authors:  Michael J Shattock; Michela Ottolia; Donald M Bers; Mordecai P Blaustein; Andrii Boguslavskyi; Julie Bossuyt; John H B Bridge; Ye Chen-Izu; Colleen E Clancy; Andrew Edwards; Joshua Goldhaber; Jack Kaplan; Jerry B Lingrel; Davor Pavlovic; Kenneth Philipson; Karin R Sipido; Zi-Jian Xie
Journal:  J Physiol       Date:  2015-03-15       Impact factor: 5.182

Review 6.  Cellular Na+ handling mechanisms involved in airway smooth muscle contraction (Review).

Authors:  Bettina Sommer; Edgar Flores-Soto; Georgina Gonzalez-Avila
Journal:  Int J Mol Med       Date:  2017-05-17       Impact factor: 4.101

Review 7.  Endogenous cardiotonic steroids and cardiovascular disease, where to next?

Authors:  Davor Pavlovic
Journal:  Cell Calcium       Date:  2019-12-27       Impact factor: 6.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.